Cargando…

Oxygen therapy may worsen the survival rate in rats with monocrotaline-induced pulmonary arterial hypertension

Although oxygen therapy rapidly improves arterial oxygen saturation in idiopathic pulmonary arterial hypertension, the effects of chronic administration of oxygen are unknown. The purpose of the present study was to investigate the effects of chronic oxygen therapy on the histological changes and su...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Naoto, Yamasaki, Natsuki, Eto, Kanako, Asaeda, Makoto, Kuwahara, Wataru, Imagita, Hidetaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147559/
https://www.ncbi.nlm.nih.gov/pubmed/30235299
http://dx.doi.org/10.1371/journal.pone.0204254
_version_ 1783356575234129920
author Fujita, Naoto
Yamasaki, Natsuki
Eto, Kanako
Asaeda, Makoto
Kuwahara, Wataru
Imagita, Hidetaka
author_facet Fujita, Naoto
Yamasaki, Natsuki
Eto, Kanako
Asaeda, Makoto
Kuwahara, Wataru
Imagita, Hidetaka
author_sort Fujita, Naoto
collection PubMed
description Although oxygen therapy rapidly improves arterial oxygen saturation in idiopathic pulmonary arterial hypertension, the effects of chronic administration of oxygen are unknown. The purpose of the present study was to investigate the effects of chronic oxygen therapy on the histological changes and survival rate in rats with idiopathic pulmonary arterial hypertension. Idiopathic pulmonary arterial hypertension was induced by monocrotaline injection. The rats were then randomly assigned to receive or not receive oxygen therapy (O(2) group and non-O(2) group, respectively). The rats in the O(2) group were exposed to a high (90%) oxygen environment from day 17 following injection of monocrotaline, when hypoxemia was first observed. The pulmonary arteriole walls were significantly thicker in monocrotaline-injected rats than in saline-injected rats as vehicle on day 19 and were significantly thicker in the rats that received oxygen therapy than in the rats that did not. Right ventricular inflammations were significantly higher in monocrotaline-injected rats than in saline-injected rats on day 19 and were significantly higher in the rats that received oxygen therapy than in the rats that did not. By day 20 after injection of monocrotaline, the survival rate was significantly lower in the rats that received oxygen therapy than in those that did not. Superoxide dismutase activity in the lungs was higher in monocrotaline-injected rats than in saline-injected rats on day 19 after monocrotaline injection and was also higher in the saline-injected rats that received oxygen therapy than in the saline-injected rats that did not. No interaction was detected between monocrotaline injection and oxygen therapy. These results suggest that chronic oxygen therapy worsens the histological changes and survival rate in idiopathic pulmonary arterial hypertension. The fact that degradation of the histological changes and survival rate was accompanied by increase in superoxide dismutase activity suggests that antioxidant capacity may contribute to the degradation.
format Online
Article
Text
id pubmed-6147559
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-61475592018-10-08 Oxygen therapy may worsen the survival rate in rats with monocrotaline-induced pulmonary arterial hypertension Fujita, Naoto Yamasaki, Natsuki Eto, Kanako Asaeda, Makoto Kuwahara, Wataru Imagita, Hidetaka PLoS One Research Article Although oxygen therapy rapidly improves arterial oxygen saturation in idiopathic pulmonary arterial hypertension, the effects of chronic administration of oxygen are unknown. The purpose of the present study was to investigate the effects of chronic oxygen therapy on the histological changes and survival rate in rats with idiopathic pulmonary arterial hypertension. Idiopathic pulmonary arterial hypertension was induced by monocrotaline injection. The rats were then randomly assigned to receive or not receive oxygen therapy (O(2) group and non-O(2) group, respectively). The rats in the O(2) group were exposed to a high (90%) oxygen environment from day 17 following injection of monocrotaline, when hypoxemia was first observed. The pulmonary arteriole walls were significantly thicker in monocrotaline-injected rats than in saline-injected rats as vehicle on day 19 and were significantly thicker in the rats that received oxygen therapy than in the rats that did not. Right ventricular inflammations were significantly higher in monocrotaline-injected rats than in saline-injected rats on day 19 and were significantly higher in the rats that received oxygen therapy than in the rats that did not. By day 20 after injection of monocrotaline, the survival rate was significantly lower in the rats that received oxygen therapy than in those that did not. Superoxide dismutase activity in the lungs was higher in monocrotaline-injected rats than in saline-injected rats on day 19 after monocrotaline injection and was also higher in the saline-injected rats that received oxygen therapy than in the saline-injected rats that did not. No interaction was detected between monocrotaline injection and oxygen therapy. These results suggest that chronic oxygen therapy worsens the histological changes and survival rate in idiopathic pulmonary arterial hypertension. The fact that degradation of the histological changes and survival rate was accompanied by increase in superoxide dismutase activity suggests that antioxidant capacity may contribute to the degradation. Public Library of Science 2018-09-20 /pmc/articles/PMC6147559/ /pubmed/30235299 http://dx.doi.org/10.1371/journal.pone.0204254 Text en © 2018 Fujita et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Fujita, Naoto
Yamasaki, Natsuki
Eto, Kanako
Asaeda, Makoto
Kuwahara, Wataru
Imagita, Hidetaka
Oxygen therapy may worsen the survival rate in rats with monocrotaline-induced pulmonary arterial hypertension
title Oxygen therapy may worsen the survival rate in rats with monocrotaline-induced pulmonary arterial hypertension
title_full Oxygen therapy may worsen the survival rate in rats with monocrotaline-induced pulmonary arterial hypertension
title_fullStr Oxygen therapy may worsen the survival rate in rats with monocrotaline-induced pulmonary arterial hypertension
title_full_unstemmed Oxygen therapy may worsen the survival rate in rats with monocrotaline-induced pulmonary arterial hypertension
title_short Oxygen therapy may worsen the survival rate in rats with monocrotaline-induced pulmonary arterial hypertension
title_sort oxygen therapy may worsen the survival rate in rats with monocrotaline-induced pulmonary arterial hypertension
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147559/
https://www.ncbi.nlm.nih.gov/pubmed/30235299
http://dx.doi.org/10.1371/journal.pone.0204254
work_keys_str_mv AT fujitanaoto oxygentherapymayworsenthesurvivalrateinratswithmonocrotalineinducedpulmonaryarterialhypertension
AT yamasakinatsuki oxygentherapymayworsenthesurvivalrateinratswithmonocrotalineinducedpulmonaryarterialhypertension
AT etokanako oxygentherapymayworsenthesurvivalrateinratswithmonocrotalineinducedpulmonaryarterialhypertension
AT asaedamakoto oxygentherapymayworsenthesurvivalrateinratswithmonocrotalineinducedpulmonaryarterialhypertension
AT kuwaharawataru oxygentherapymayworsenthesurvivalrateinratswithmonocrotalineinducedpulmonaryarterialhypertension
AT imagitahidetaka oxygentherapymayworsenthesurvivalrateinratswithmonocrotalineinducedpulmonaryarterialhypertension